はじめての方へ
ショーケース
価格
ログイン
無料体験
米国企業
Denali Therapeutics Inc.
Denali Therapeutics Inc.
DNLI
時価総額
$28.5億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
iso4217:USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2023年
12月31日
Collaboration revenue from customers
331
Research and development expense
424
General and administrative
103
Total operating expenses
527
Research and development expense
424
General and administrative
103
Total operating expenses
527
Loss from operations
-197
Loss from operations
-197
Nonoperating Income (Expense)
52
Nonoperating Income (Expense)
52
Loss before income taxes
-145
Loss before income taxes
-145
Income tax benefit (expense)
0
Income tax benefit (expense)
0
Net loss
-145
Net loss
-145
Net unrealized gain (loss) on marketable securities, net of tax
8
Net unrealized gain (loss) on marketable securities, net of tax
8
Comprehensive loss
-138
Comprehensive loss
-138
Earnings Per Share, Basic
-1.06
Earnings Per Share, Diluted
-1.06
Earnings Per Share, Basic
-1.06
Earnings Per Share, Diluted
-1.06
Earnings Per Share, Basic
-1.06
Earnings Per Share, Diluted
-1.06